keyword
https://read.qxmd.com/read/37861679/discovery-of-mk-1468-a-potent-kinome-selective-brain-penetrant-amidoisoquinoline-lrrk2-inhibitor-for-the-potential-treatment-of-parkinson-s-disease
#21
JOURNAL ARTICLE
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, Mitchell H Keylor, Michael Ardolino, Xin Yan, Rebecca Johnson, Rachel L Palte, Spencer E McMinn, Lisa Nogle, Jing Su, Dong Xiao, Jennifer Piesvaux, Susi Lee, Laxminarayan G Hegde, Janice D Woodhouse, Robert Faltus, Lily Y Moy, Tina Xiong, Paul J Ciaccio, Kara Pearson, Mayankbhai Patel, Karin M Otte, Cheryl E G Leyns, Matthew E Kennedy, David Jonathan Bennett, Erin F DiMauro, Matthew J Fell, Peter H Fuller
Genetic mutation of the leucine-rich repeat kinase 2 (LRRK2) protein has been associated with Parkinson's disease (PD), a disabling and progressive neurodegenerative disorder that is devoid of efficacious disease-modifying therapies. Herein, we describe the invention of an amidoisoquinoline (IQ)-derived LRRK2 inhibitor lead chemical series. Knowledge-, structure-, and property-based drug design in concert with rigorous application of in silico calculations and presynthesis predictions enabled the prioritization of molecules with favorable CNS "drug-like" physicochemical properties...
October 20, 2023: Journal of Medicinal Chemistry
https://read.qxmd.com/read/37842167/transfer-rna-mediated-restoration-of-potassium-current-and-electrical-correction-in-premature-termination-long-qt-syndrome-herg-mutants
#22
JOURNAL ARTICLE
Viggo G Blomquist, Jacqueline Niu, Papiya Choudhury, Ahmad Al Saneh, Henry M Colecraft, Christopher A Ahern
Disease-causing premature termination codons (PTCs) individually disrupt the functional expression of hundreds of genes and represent a pernicious clinical challenge. In the heart, loss-of-function mutations in the hERG potassium channel account for approximately 30% of long-QT syndrome arrhythmia, a lethal cardiac disorder with limited treatment options. Premature termination of ribosomal translation produces a truncated and, for potassium channels, a potentially dominant-negative protein that impairs the functional assembly of the wild-type homotetrameric hERG channel complex...
December 12, 2023: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/37796721/diterpenoids-from-euphorbia-fischeriana-with-kv1-3-inhibitory-activity
#23
JOURNAL ARTICLE
Qin Cai, Hong-Jing Zha, Shi-Ying Yuan, Xing Sun, Xin Lin, Xin-Yu Zheng, Ying-Xian Qian, Ru-Feng Xia, Yue-Shan Luo, Zhimian Shi, Jun-Cheng Su, Luo-Sheng Wan
Euphorbia diterpenoids possess inhibitory effects of Kv1.3 ion channel, but most of this research has focused on diterpenoids with jatrophane-related or ingenane-related skeletons. In the present study, nine undescribed ( 1 - 9 ) and 16 known ( 10 - 25 ) diterpenoids, based on jatrophane, lathyrane, ingenane, abietane, and atisane skeletons, were identified from the methanol extract of the aerial parts of Euphorbia fischeriana . The structures were established by analysis of the spectroscopic data as well as by single-crystal X-ray diffraction analysis...
October 5, 2023: Journal of Natural Products
https://read.qxmd.com/read/37759755/the-potential-mechanisms-behind-loperamide-induced-cardiac-arrhythmias-associated-with-human-abuse-and-extreme-overdose
#24
JOURNAL ARTICLE
Hua Rong Lu, Bruce P Damiano, Mohamed Kreir, Jutta Rohrbacher, Henk van der Linde, Tamerlan Saidov, Ard Teisman, David J Gallacher
Loperamide has been a safe and effective treatment for diarrhea for many years. However, many cases of cardiotoxicity with intentional abuse of loperamide ingestion have recently been reported. We evaluated loperamide in in vitro and in vivo cardiac safety models to understand the mechanisms for this cardiotoxicity. Loperamide slowed conduction (QRS-duration) starting at 0.3 µM [~1200-fold (×) its human Free Therapeutic Plasma Concentration; FTPC] and reduced the QT-interval and caused cardiac arrhythmias starting at 3 µM (~12,000× FTPC) in an isolated rabbit ventricular-wedge model...
September 6, 2023: Biomolecules
https://read.qxmd.com/read/37702218/ich-s7b-in-vitro-assays-do-not-address-mechanisms-of-qt-c-prolongation-for-peptides-and-proteins-data-in-support-of-not-needing-dedicated-qt-c-studies
#25
JOURNAL ARTICLE
Wendy W Wu, Moran Choe, Lars Johannesen, Jose Vicente, Girish Bende, Norman L Stockbridge, David G Strauss, Christine Garnett
Current cardiac safety testing focuses on detecting drug-induced QTC prolongation as a surrogate for risk of Torsade de Pointes. The nonclinical strategy, described in ICH S7B, includes in vitro assessment of hERG block or ventricular repolarization delay and in vivo QT prolongation. Several studies have reported predictive values of ICH S7B results for clinical QTC outcomes for small molecules; none has examined peptides and proteins other than monoclonal antibodies. To address this knowledge gap, information for peptides and proteins submitted to the FDA was collected...
September 13, 2023: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/37691654/4-phenylbutyric-acid-re-trafficking-herg-g572r-channel-protein-by-modulating-the-endoplasmic-reticulum-stress-associated-chaperones-and-endoplasmic-reticulum-associated-degradation-gene
#26
JOURNAL ARTICLE
Wen Tang, Dihui Cai, Yin Fu, Zequn Zheng, Xiaoyan Huang, Rami N Khouzam, Yongfei Song, Jiangfang Lian
BACKGROUND: Long QT syndrome type 2 (LQT2) is caused by mutations in the KCNH2 /human ether-à-go-go-related gene (hERG). Some hERG genetic mutation-associated diseases are alleviated by hERG-specific drug chaperones (glycerol, dimethyl sulfoxide, trimethylamine N-oxide, thapsigargin), delayed rectifier K+ current (IKr) blockers methanesulfonanilide E4031, the antihistamine astemizole, or the prokinetic drug cisapride, and the anti-arrhythmic drug quinidine. Meanwhile, many in vivo and in vitro studies have reported the efficacy of 4-phenylbutyric acid (4-PBA) in diseases with inherited genetic mutations...
August 31, 2023: Journal of Thoracic Disease
https://read.qxmd.com/read/37649890/assessment-of-the-proarrhythmic-effects-of-repurposed-antimalarials-for-covid-19-treatment-using-a-comprehensive-in-vitro-proarrhythmia-assay-cipa
#27
JOURNAL ARTICLE
Seung-Hyun Yoon, Hyun-Lee Lee, Da Un Jeong, Ki Moo Lim, Seong-Jun Park, Ki-Suk Kim
Due to the outbreak of the SARS-CoV-2 virus, drug repurposing and Emergency Use Authorization have been proposed to treat the coronavirus disease 2019 (COVID-19) during the pandemic. While the efficiency of the drugs has been discussed, it was identified that certain compounds, such as chloroquine and hydroxychloroquine, cause QT interval prolongation and potential cardiotoxic effects. Drug-induced cardiotoxicity and QT prolongation may lead to life-threatening arrhythmias such as torsades de pointes (TdP), a potentially fatal arrhythmic symptom...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37640910/cell-free-synthesis-and-electrophysiological-analysis-of-multipass-voltage-gated-ion-channels-tethered-in-microsomal-membranes
#28
JOURNAL ARTICLE
Yogesh Pandey, Srujan Kumar Dondapati, Doreen Wüstenhagen, Stefan Kubick
Cell-free protein synthesis (CFPS) has emerged as a powerful tool for the rapid synthesis and analysis of various structurally and functionally distinct proteins. These include 'difficult-to-express' membrane proteins such as large multipass ion channel receptors. Owing to their membrane localization, eukaryotic CFPS supplemented with endoplasmic reticulum (ER)-derived microsomal vesicles has proven to be an efficient system for the synthesis of functional membrane proteins. Here we demonstrate the applicability of the eukaryotic cell-free systems based on lysates from the mammalian Chinese Hamster Ovary (CHO) and insect Spodoptera frugiperda (Sf21) cells...
August 29, 2023: Advances in Biochemical Engineering/biotechnology
https://read.qxmd.com/read/37375326/synthesis-and-receptor-binding-studies-of-%C3%AE-5-gaba-a-r-selective-novel-imidazodiazepines-targeted-for-psychiatric-and-cognitive-disorders
#29
JOURNAL ARTICLE
Dishary Sharmin, Md Yeunus Mian, Michael Marcotte, Thomas D Prevot, Etienne Sibille, Jeffrey M Witkin, James M Cook
GABA mediates inhibitory actions through various GABAA receptor subtypes, including 19 subunits in human GABAAR. Dysregulation of GABAergic neurotransmission is associated with several psychiatric disorders, including depression, anxiety, and schizophrenia. Selective targeting of α2/3 GABAARs can treat mood and anxiety, while α5 GABAA-Rs can treat anxiety, depression, and cognitive performance. GL-II-73 and MP-III-022, α5-positive allosteric modulators have shown promising results in animal models of chronic stress, aging, and cognitive disorders, including MDD, schizophrenia, autism, and Alzheimer's disease...
June 14, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37346394/pillar-6-maxq-a-potent-supramolecular-host-for-in-vivo-sequestration-of-methamphetamine-and-fentanyl
#30
JOURNAL ARTICLE
Adam T Brockett, Weijian Xue, David King, Chun-Lin Deng, Canjia Zhai, Michael Shuster, Shivangi Rastogi, Volker Briken, Matthew R Roesch, Lyle Isaacs
Pillar[6]MaxQ (P6AS) functions as an in vivo sequestration agent for methamphetamine and fentanyl. We use 1 H NMR, isothermal titration calorimetry, and molecular modelling to deduce the geometry and strength of the P6AS•drug complexes. P6AS forms tight complexes with fentanyl (Kd =9.8 nM), PCP (17.1 nM), MDMA (25.5 nM), mephedrone (52.4 nM), and methamphetamine (101 nM). P6AS has good in vitro biocompatibility according to MTS metabolic, Adenylate Kinase cell death, and hERG ion channel inhibition assays, and the Ames fluctuation test...
April 13, 2023: Chem
https://read.qxmd.com/read/37324483/acute-osimertinib-exposure-induces-electrocardiac-changes-by-synchronously-inhibiting-the-currents-of-cardiac-ion-channels
#31
JOURNAL ARTICLE
Peiwen Li, Xiaohui Tian, Gongxin Wang, Enshe Jiang, Yanming Li, Guoliang Hao
Introduction: As the third generation of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), osimertinib has demonstrated more significant cardiotoxicity than previous generations of EGFR-TKIs. Investigating the mechanism of osimertinib cardiotoxicity can provide a reference for a comprehensive understanding of osimertinib-induced cardiotoxicity and the safety of the usage of this drug in clinical practice. Methods: Multichannel electrical mapping with synchronous ECG recording was used to investigate the effects of varying osimertinib concentrations on electrophysiological indicators in isolated Langendorff-perfused hearts of guinea pigs...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37159454/mechanisms-underlying-the-antiarrhythmic-effect-of-arumenamide-787-in-experimental-models-of-the-j-wave-syndromes-and-hypothermia
#32
JOURNAL ARTICLE
José M Di Diego, Hector Barajas-Martinez, Robert Cox, Victoria M Robinson, Joseph Jung, Mohamed Fouda, Mena Abdelsayed, Peter C Ruben, Charles Antzelevitch
BACKGROUND: Brugada (BrS) and early repolarization syndromes (ERS), the so-called J wave syndromes (JWS), are associated with life-threatening ventricular arrhythmias. Pharmacologic approaches to therapy are currently limited. In this study, we examine the effects of ARumenamide-787 (AR-787) to suppress the electrocardiographic and arrhythmic manifestations of JWS and hypothermia. METHODS: We studied the effects of AR-787 on INa and IKr in HEK-293 cells stably expressing the α- and β1-subunits of the cardiac (NaV1...
2023: PloS One
https://read.qxmd.com/read/37111245/abt-333-dasabuvir-increases-action-potential-duration-and-provokes-early-afterdepolarizations-in-canine-left-ventricular-cells-via-inhibition-of-i-kr
#33
JOURNAL ARTICLE
Zsigmond Máté Kovács, József Óvári, Csaba Dienes, János Magyar, Tamás Bányász, Péter P Nánási, Balázs Horváth, Adam Feher, Zoltan Varga, Norbert Szentandrássy
ABT-333 (dasabuvir) is an antiviral agent used in hepatitis C treatment. The molecule, similarly to some inhibitors of hERG channels, responsible for the delayed rectifier potassium current (IKr ), contains the methanesulfonamide group. Reduced IKr current leads to long QT syndrome and early afterdepolarizations (EADs), therefore potentially causing life-threatening arrhythmias and sudden cardiac death. Our goal was to investigate the acute effects of ABT-333 in enzymatically isolated canine left ventricular myocardial cells...
March 25, 2023: Pharmaceuticals
https://read.qxmd.com/read/37110748/an-insight-into-the-potassium-currents-of-herg-and-their-simulation
#34
JOURNAL ARTICLE
Rolando Guidelli
By assuming that a stepwise outward movement of the four S4 segments of the hERG potassium channel determines a concomitant progressive increase in the flow of the permeant potassium ions, the inward and outward potassium currents can be simulated by using only one or two adjustable (i.e., free) parameters. This deterministic kinetic model differs from the stochastic models of hERG available in the literature, which usually require more than 10 free parameters. The K+ outward current of hERG contributes to the repolarization of the cardiac action potential...
April 16, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37054759/synthesis-and-biological-evaluation-of-biaryl-alkyl-ethers-as-inhibitors-of-ido1
#35
JOURNAL ARTICLE
Jay A Markwalder, Aaron J Balog, David K Williams, Susheel J Nara, Ratnakar Reddy, Saumya Roy, Yadagiri Kanyaboina, Xin Li, Kathy Johnston, Yi Fan, Hal Lewis, Frank Marsilio, Chunhong Yan, David Critton, John A Newitt, Sarah C Traeger, Dauh-Rurng Wu, Maria N Jure-Kunkel, Lata Jayaraman, Tai-An Lin, Michael W Sinz, John T Hunt, Steven P Seitz
Starting from the dialkylaniline indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor lead 3 (IDO1 HeLa IC50 = 7.0 nM), an iterative process of synthesis and screening led to cyclized analog 21 (IDO1 HeLa IC50 = 3.6 nM) which maintained the high potency of 3 while addressing issues of lipophilicity, cytochrome P450 (CYP) inhibition, hERG (human potassium ion channel Kv11.1) inhibition, Pregnane X Receptor (PXR) transactivation, and oxidative metabolic stability. An x-ray crystal structure of a biaryl alkyl ether 11 bound to IDO1 was obtained...
April 11, 2023: Bioorganic & Medicinal Chemistry Letters
https://read.qxmd.com/read/37037115/inhibition-of-the-herg-potassium-ion-channel-by-different-non-nucleoside-human-cytomegalovirus-polymerase-antiviral-inhibitor-series-and-the-exploration-of-variations-on-a-pyrroloquinoline-core-to-reduce-cardiotoxicity-potential
#36
JOURNAL ARTICLE
Appan Srinivas Kandadai, Bing Bai, Mohammad Rahim, Fusen Lin, Zhengxian Gu, Xinyi Qi, Xuecheng Zhang, Haiheng Dong, Ying Chen, John Shen, James A Nieman
Many non-nucleoside human cytomegalovirus (HCMV) inhibitors have been reported in patent and scientific literature, however, none have reached commercialization despite the urgent need for new HCMV treatments. Herein we report select compounds from different templates that all had low micromolar human ether-à-go-go (hERG) ion channel IC50 values. We also describe a series of pyrroloquinoline derivatives that were designed and synthesized to understand the effect of various substitution on human cytomegalovirus (HCMV) polymerase activity, antiviral activity, and hERG inhibition...
April 5, 2023: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/37015297/opioids-induced-inhibition-of-herg-ion-channels-and-sudden-cardiac-death-a-systematic-review-of-current-literature
#37
REVIEW
Adham El Sherbini, Kiera Liblik, Junsu Lee, Adrian Baranchuk, Shetuan Zhang, Mohammad El-Diasty
BACKGROUND: It is estimated that over 60 million individuals regularly use opioids globally, with opioid use disorder increasing substantially in the past decade. Several reports have linked sudden cardiac death, QTc prolongation, and other adverse cardiovascular outcomes with opioid use through their inhibitory effect on the human ether-a-go-go-related gene (HERG) ion channel. Therefore, understanding this underlying mechanism may be critical for risk prevention and management in prescribing opioids and treating patients with opioid dependency...
April 2, 2023: Trends in Cardiovascular Medicine
https://read.qxmd.com/read/36982449/pro-arrhythmic-potential-of-accumulated-uremic-toxins-is-mediated-via-vulnerability-of-action-potential-repolarization
#38
JOURNAL ARTICLE
Willem B van Ham, Carlijn M Cornelissen, Elizaveta Polyakova, Stephanie M van der Voorn, Merel L Ligtermoet, Jantine Monshouwer-Kloots, Marc A Vos, Alexandre Bossu, Eva van Rooij, Marcel A G van der Heyden, Toon A B van Veen
Chronic kidney disease (CKD) is represented by a diminished filtration capacity of the kidneys. End-stage renal disease patients need dialysis treatment to remove waste and toxins from the circulation. However, endogenously produced uremic toxins (UTs) cannot always be filtered during dialysis. UTs are among the CKD-related factors that have been linked to maladaptive and pathophysiological remodeling of the heart. Importantly, 50% of the deaths in dialysis patients are cardiovascular related, with sudden cardiac death predominating...
March 11, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36860515/a-need-for-exhaustive-and-standardized-characterization-of-ion-channels-activity-the-case-of-k-v-11-1
#39
REVIEW
Malak Alameh, Barbara Ribeiro Oliveira-Mendes, Florence Kyndt, Jordan Rivron, Isabelle Denjoy, Florian Lesage, Jean-Jacques Schott, Michel De Waard, Gildas Loussouarn
hERG, the pore-forming subunit of the rapid component of the delayed rectifier K+ current, plays a key role in ventricular repolarization. Mutations in the KCNH2 gene encoding hERG are associated with several cardiac rhythmic disorders, mainly the Long QT syndrome (LQTS) characterized by prolonged ventricular repolarization, leading to ventricular tachyarrhythmias, sometimes progressing to ventricular fibrillation and sudden death. Over the past few years, the emergence of next-generation sequencing has revealed an increasing number of genetic variants including KCNH2 variants...
2023: Frontiers in Physiology
https://read.qxmd.com/read/36834837/structure-function-studies-of-sponge-derived-compounds-on-the-cardiac-ca-v-3-1-channel
#40
JOURNAL ARTICLE
Anne-Sophie Depuydt, Piyush A Patel, Žan Toplak, Chinmaya Bhat, Manuela Voráčová, Irene Eteläinen, Fiammetta Vitulano, Tanja Bruun, Antti Lempinen, Nives Hribernik, Eero Mäki-Lohiluoma, Louise Hendrickx, Ernesto Lopes Pinheiro-Junior, Tihomir Tomašič, Lucija Peterlin Mašič, Jari Yli-Kauhaluoma, Paula Kiuru, Jan Tytgat, Steve Peigneur
T-type calcium (CaV 3) channels are involved in cardiac automaticity, development, and excitation-contraction coupling in normal cardiac myocytes. Their functional role becomes more pronounced in the process of pathological cardiac hypertrophy and heart failure. Currently, no CaV 3 channel inhibitors are used in clinical settings. To identify novel T-type calcium channel ligands, purpurealidin analogs were electrophysiologically investigated. These compounds are alkaloids produced as secondary metabolites by marine sponges, and they exhibit a broad range of biological activities...
February 8, 2023: International Journal of Molecular Sciences
keyword
keyword
24026
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.